Intellectual Property India Publishes Patent Application for Improved Manufacturing Of Car T Drug Products Based On Car

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617071978 A) filed by Janssen Biotech, Inc. on June 10, 2026, for Improved Manufacturing Of Car T Drug Products Based On Car.

Inventors include Magge Ranganatha, Arjun; Javidi, Alex; Lu, Hoang; Henckels, Eric Number; Ciccone, Daniel; Morris, Donald; and Bowden, Robert.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Systems and methods are disclosed for predicting a chimeric antigen receptor (CAR) in a patient-specific CAR T drug product for a target patient. An example method includes: receiving quantitative data for a set of CAR parameters; generating an input feature vector comprising the quantitative data for the set of CAR parameters; and applying, into a trained machine learning model, the input feature vector to generate an output feature vector predicting the CAR.

Disclaimer: Curated by HT Syndication.